Pfizer identifies emerging markets for future growth
This article was originally published in Scrip
Executive Summary
Pfizerplans to offset the generic erosion of Lipitor (simvastatin) sales by driving growth in emerging markets and reworking its sales operations. Pfizer’s president of worldwide pharmaceutical operations, Ian Read, outlined the plan at the UBS global life science conference before addressing the future of the cholesterol drug.